Express Pharma - Page 269 of 2194 - Express Pharma

Panel Discussion: India as an injectable hub: Growing CDMO strength and global partnerships

Mr Sridhar Balasubramanian, Head Quality – Sterile / Parenteral, Dr Reddy’s Laboratories

Panel Discussion: Beyond generics: Moving into complex injectables, oncology and biosimilars

PURIFY’24 West to mark its 5th edition of PURIFY conferences

Moving Your Lab? Make Science Your Priority – Agilent CrossLab Relocation Services

Aurigene Pharma announces the opening of its biologics facility

Lupin receives tentative approval from U.S. FDA for Letermovir tablets

Bionova Scientific announces $100 million investment in new Plasmid DNA facility

Moderna receives U.S. FDA approval for RSV vaccine mRESVIA(R)

Lupin launches Doxycycline for Injection USP in the United States

Amylyx’s efforts to explore other indications for Relyvrio seems to be bearing fruit: GlobalData

TAGRISSO reduces disease progression or death by 84 % in Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial

Puma Biotechnology announces presentation of findings from a phase II study of alisertib in endocrine-resistant metastatic breast cancer